A previous study showed that goal-directed fluid therapy, which targets continuously measured hemodynamic variables, such as cardiac output, stroke volume, and pulse pressure variation, decreases fluid balance compared with normal infusion therapy; such a therapy also reduces inflammatory reactions, including TNF-α and IL-6, after lung cancer surgery [29]. The gene discussed is TNF; the disease is lung carcinoma.